[go: up one dir, main page]

WO2017200243A1 - Système pour soigner une maladie mentale employant un contenu soutenu par une réalité virtuelle et le résultat d'une analyse de bio-signaux - Google Patents

Système pour soigner une maladie mentale employant un contenu soutenu par une réalité virtuelle et le résultat d'une analyse de bio-signaux Download PDF

Info

Publication number
WO2017200243A1
WO2017200243A1 PCT/KR2017/004998 KR2017004998W WO2017200243A1 WO 2017200243 A1 WO2017200243 A1 WO 2017200243A1 KR 2017004998 W KR2017004998 W KR 2017004998W WO 2017200243 A1 WO2017200243 A1 WO 2017200243A1
Authority
WO
WIPO (PCT)
Prior art keywords
symptom
virtual reality
user
content
biosignal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2017/004998
Other languages
English (en)
Korean (ko)
Inventor
신호철
이상훈
김석민
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meddiction Corp
Original Assignee
Meddiction Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meddiction Corp filed Critical Meddiction Corp
Publication of WO2017200243A1 publication Critical patent/WO2017200243A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/024—Measuring pulse rate or heart rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0531—Measuring skin impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/389—Electromyography [EMG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
    • G06Q50/10—Services
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T19/00—Manipulating 3D models or images for computer graphics
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T19/00—Manipulating 3D models or images for computer graphics
    • G06T19/006—Mixed reality
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Definitions

  • the present invention relates to a system for improving mental disorders, and in detail, by changing a virtual environment so that mental disorders can be improved in real time by analyzing a change in a biosignal of a user in contact with contents of a virtual environment and analyzing the result.
  • the present invention relates to a system for improving mental disorders using virtual reality support contents and biosignal analysis results to improve and improve various mental disorders such as addiction disease, depression, anxiety, and stress disorder.
  • the systematic desensitization method is to reduce the fear of the fear-inducing situation by using the muscle relaxation method along with imagining the fear-inducing situation. And the final stage of treatment is to go to the environment where you are actually experiencing anxiety and experience it yourself.
  • this conventional method has a problem in that it is not generalized because there is a lack of a method that can change various situations required to implement the virtual environment in accordance with the symptoms in order to maximize the effect of the treatment. That is, in the related art, only the preset virtual reality contents are provided only according to the mental symptoms of the patient, and since the virtual reality cannot be accurately realized in real time to match the psychological state or symptoms of the patient, the treatment method using the virtual reality This generalization is not generalized and its effect is insignificant.
  • an object of the present invention for solving the above problems is to provide a real-time analysis of the change in the bio-signal of the user in contact with the content of the virtual environment and by changing the virtual environment to improve the mental disorders in conjunction with the analysis results It provides a mental disease improvement system that utilizes virtual reality support contents and biosignal analysis results to improve and improve various mental diseases such as addiction disease, depression, anxiety and stress disease.
  • a system for improving mental disorders using virtual reality support contents and biosignal analysis results includes a virtual apparatus including symptom-inducing or symptom-enhancing content so that a user may access virtual reality.
  • a virtual environment realization device that provides environmental contents
  • a biosignal detection device that detects and biometrics a user's biosignal in real time, and shares the data of the biosignal information, and monitors and analyzes a user's biosignal change state in real time to
  • a monitoring controller configured to selectively provide symptom-inducing or symptom-enhancing content according to state and physical condition.
  • the change in the biosignal of the user in contact with the content of the virtual environment is analyzed in real time and linked with the analyzed result.
  • FIG. 1 is a block diagram schematically illustrating the configuration of a system for improving mental disorders using virtual reality support contents and biosignal analysis results according to an exemplary embodiment of the present invention.
  • FIG. 2 is a diagram illustrating in detail the configuration of the virtual environment implementing apparatus of FIG. 1.
  • FIG. 3 is a block diagram illustrating in detail the configuration of the apparatus for detecting a biosignal shown in FIG. 1.
  • FIG. 4 is a block diagram illustrating in detail the configuration of the monitoring control unit illustrated in FIG. 1.
  • FIG. 5 is a flowchart sequentially illustrating a control operation of the monitoring controller illustrated in FIG. 4.
  • FIG. 6 is a diagram illustrating a symptom improving virtual environment content supporting method of the symptom improving support unit of FIG. 5.
  • FIG. 1 is a block diagram schematically illustrating the configuration of a system for improving mental disorders using virtual reality support contents and biosignal analysis results according to an exemplary embodiment of the present invention.
  • the mental disorder improvement system illustrated in FIG. 1 includes a virtual environment implementation apparatus 100 that provides virtual environment contents including a symptom-inducing or symptom-enhancing content selectively so that a user may come into contact with virtual reality, and a living body of the user in contact with the virtual reality.
  • the biosignal detection apparatus 200 which detects data in real time and converts the data into biosignal information, and monitors and analyzes the biosignal change state of the user in real time to cause or cause symptoms according to the mental and physical state of the user.
  • the monitoring control unit 300 and the monitoring control unit 300 to selectively provide the improved content, and provide the biological signal analysis reference data to the monitoring control unit 300 to support the analysis process and the mental state and physical state analyzed by the monitoring control unit 300 In addition to storing the analysis results, the symptom-inducing content and symptoms described above It is configured to include a management server 400 that supports the content.
  • the virtual environment implementation apparatus 100 provides virtual environment content so that the user may encounter virtual reality, where the virtual environment content is symptom-induced content for inducing the user's mental symptoms and symptom improvement for alleviating the user's mental symptoms.
  • the content is classified and provided.
  • the user may have various mental symptoms related to stress disorders in the life as well as mental illnesses such as addiction disease, depression, and anxiety. Accordingly, after providing symptom-induced content for inducing the mental symptoms in virtual reality, the symptom-improved content for alleviating mental symptoms may be provided in virtual reality depending on the biosignal analysis result.
  • the virtual environment implementing apparatus 100 may visually use virtual reality, augmented reality, 3D hologram, etc. to provide virtual environment contents including symptom causing or symptom improving contents.
  • the audio providing tool, the olfactory olfactory expression tool, and the haptic tool may be configured to be utilized.
  • the biosignal detection apparatus 200 detects and converts a biosignal of a user in contact with a virtual reality in real time to share data.
  • the biosignal detecting apparatus 200 may include a user's biosignal, for example, heart rate (HR), brain wave (EEG), electrocardiogram (ECG), electromyogram (EMG), skin resistance (GSR), HRV (heart rate variability).
  • HR heart rate
  • ECG brain wave
  • ECG electrocardiogram
  • EMG electromyogram
  • GSR skin resistance
  • HRV heart rate variability
  • the biosignal detection apparatus 200 detects and converts the biosignal of the user in contact with the virtual reality in real time to share the data.
  • the biosignal detecting apparatus 200 may include a user's biosignal, for example, heart rate (HR), brain wave (EEG), electrocardiogram (ECG), electromyogram (EMG), skin resistance (GSR), HRV (heart rate variability).
  • HR heart rate
  • ECG brain wave
  • ECG electrocardiogram
  • EMG electromyogram
  • GSR skin resistance
  • HRV heart rate variability
  • the monitoring control unit 300 receives the biosignal information that is dataized through the biosignal detection apparatus 200 and monitors and analyzes the user's biosignal change state in real time according to the biosignal information.
  • the symptom-inducing or symptom-enhancing content is selectively provided according to the analyzed mental state and the physical state of the user so that the user's heart disease can be improved.
  • the monitoring controller 300 first simulates the user with symptom-induced content related to the fire for the purpose of treatment.
  • the user When exposed to a fire environment, the user may experience severe anxiety and an increase in heart rate or high beta waveforms associated with anxiety in EEG.
  • the anxiety symptoms are alleviated by providing a stable virtual environment with symptom-enhancing content.
  • the monitoring control unit 300 selectively provides the virtual reality by the symptom-induced content and the virtual reality by the symptom-enhancing content according to the user's mental symptoms, but the user's body and psychology by the biosignal analysis algorithm. By adjusting the level of symptom induction or symptom improvement according to the condition, the virtual reality is improved and treated.
  • the management server 400 supports the physical and psychological state analysis process by providing the biosignal analysis reference data to the monitoring control unit 300, and stores the mental state and physical state analysis results analyzed by the monitoring control unit 300. .
  • various types of symptom-induced content and symptom improvement content are pre-set in the virtual environment implementing apparatus 100 so as to meet the control of the monitoring controller 300.
  • the management server 400 may store treatment information related to the mental state and the physical state analysis result of the user in advance and provide the same to the user or the monitoring control unit 300.
  • FIG. 2 is a diagram illustrating in detail the configuration of the virtual environment implementing apparatus of FIG. 1.
  • the apparatus 100 for implementing a virtual environment includes an image display module 110, an audio module 120, a fragrance expression module 130, a haptic module 140, and a virtual environment support control unit 150. Can be configured.
  • the image display module 110 visually provides virtual reality content by symptom-induced or symptom-enhanced content by selectively utilizing virtual reality, augmented reality, or 3D hologram.
  • the image display module 110 may be configured as a flat screen on which 3D holograms or 3D images are displayed, or a virtual reality headset or a tablet mobile communication device may be utilized. In the drawings of the present invention, only the example in which the virtual reality headset is applied is shown.
  • the audio module 120 is configured of an external speaker headset or earphone, and provides the user with an acoustic sound of virtual reality content by symptom-inducing or symptom-enhancing content.
  • the fragrance expression module 130 is composed of a fragrance apparatus or a spray type module that expresses a predetermined fragrance to provide olfactory fragrance of virtual reality content by symptom-inducing or symptom-enhancing content.
  • the haptic module 140 is applied to be connected to the skin of the user's hand or foot to provide a tactile sense of the virtual reality content by the symptom causing or symptom improving content directly to the user's skin.
  • the virtual environment support control unit 150 is an image display module 110 and an audio module 120 in response to symptom-induced content or symptom-enhanced content that are stored in advance or provided from the management server 400 under the control of the monitoring controller 300. , Selectively control and drive the scent expression module 130, and the haptic module 140.
  • FIG. 3 is a block diagram illustrating in detail the configuration of the apparatus for detecting a biosignal shown in FIG. 1.
  • the biosignal detection apparatus 200 shown in FIG. 3 detects and converts a biosignal of a user in contact with a virtual reality in real time, and shares the data of the biosignal information. For this purpose, the biosignal detection apparatus 200 measures a cerebral signal.
  • a unit 210, a heart signal measuring unit 220, a muscle signal measuring unit 230, a skin and body temperature signal measuring unit 240, an A / D converter 250, and a first communication unit 260 are provided. It is composed.
  • biosignal detecting apparatus 200 may further include an eyeball and a face signal measuring unit 270.
  • the cerebral signal measuring unit 210 detects EEG of a user in contact with virtual reality in real time and measures an EEG signal in real time, and the measured signal is converted into an A / D converter 250 and a first communication unit ( 260).
  • the cardiac signal measuring unit 220 detects the electrocardiogram (ECG) and HRV (heart rate variability) of the user in contact with the virtual reality, and measures the electrocardiogram and heart rate signals in real time, and converts the measured signals in real time into the A / D converter ( 250) and the first communication unit 260.
  • ECG electrocardiogram
  • HRV heart rate variability
  • the muscle signal measuring unit 230 detects EMG of the user in contact with the virtual reality, measures the EMG signal in real time, and transmits the measured signal to the A / D converter 250 and the first communication unit 260. do.
  • Skin and body temperature signal measurement unit 240 detects the body temperature and skin resistance (GSR) of the user in contact with the virtual reality in real time to measure the skin resistance signal, the real-time measured signal A / D conversion unit 250 And transmits to the first communication unit 260.
  • GSR body temperature and skin resistance
  • the eye and face signal measuring unit 270 detects changes in pupil size, eye movement, and facial muscles of the user in contact with virtual reality to measure eye tracking information and facial expression changes in real time, and measured eye tracking information and facial expressions measured in real time.
  • the change is transmitted to the A / D converter 250 and the first communication unit 260.
  • the A / D converter 250 converts analog signals according to heart rate (HR), brain wave (EEG), electrocardiogram (ECG), electrocardiogram (EMG), skin resistance (GSR) and HRV (heart rate variability) into real-time digital data.
  • HR heart rate
  • ECG brain wave
  • ECG electrocardiogram
  • EMG electrocardiogram
  • GSR skin resistance
  • HRV heart rate variability
  • the A / D converter 250 may include heart rate (HR), brain wave (EEG), electrocardiogram (ECG), electromyogram (EMG), skin resistance (GSR), HRV (heart rate variability), pupil size, eye movement,
  • HR heart rate
  • ECG electrocardiogram
  • EMG electromyogram
  • GSR skin resistance
  • HRV heart rate variability
  • the first communication unit 260 transmits EEG signals, ECG and heart rate signals, EMG signals, skin resistance and body temperature signals to the monitoring control unit 300 and the management server 400 in real time to be shared.
  • the first communicator 260 transmits EEG signals, ECG and heart rate signals, EMG signals, skin resistance and body temperature signals, eye tracking information, and facial expression changes to the monitoring controller 300 and the management server 400 in real time. Be sure to
  • FIG. 4 is a block diagram illustrating in detail the configuration of the monitoring control unit illustrated in FIG. 1.
  • the monitoring control unit 300 shown in FIG. 4 receives the biosignal information, which is data, through the biosignal detection apparatus 200, and monitors and analyzes the biosignal change state of the user according to the biosignal information in real time.
  • the symptom-inducing or symptom-enhancing content is selectively provided according to the analyzed mental state and the physical state of the user so that the user's heart disease can be improved.
  • the monitoring control unit 300 includes a symptom induction support unit 310, a biosignal display unit 320, a biosignal analysis unit 330, a symptom improvement supporter 340, a content control unit 350, and a second communication unit 360. It can be configured with.
  • the symptom-inducing support unit 310 supports symptom-inducing content corresponding to the symptom-inducing level so that virtual reality for symptom-inducing is supported according to the determined mental symptom of the user.
  • the biosignal display unit 320 receives the biosignal information that is dataized through the biosignal detection apparatus 200 in real time and displays the user's biosignal change state in real time according to the biosignal information.
  • the biosignal analyzer 330 determines the mental state and the physical state of the user in real time by comparing and analyzing the data-signed biosignal information with preset biosignal analysis reference data (reference value). . The determination result is then provided to the content control unit 350.
  • the symptom improvement support unit 340 supports the symptom improvement contents corresponding to the symptom improvement level so that the virtual reality for symptom improvement corresponding to the mental state and the physical state information of the user is supported under the control of the content control unit 350. do.
  • the content controller 350 selectively and repeatedly provides virtual reality by symptom-induced content and virtual reality by symptom-enhancing content according to the mental and physical state of the user determined by the biosignal analyzer 330.
  • the content controller 350 controls the symptom induction or symptom improvement level to be provided to the virtual reality according to the user's physical and psychological state by the biosignal analysis algorithm.
  • the content control unit 350 selectively and repeatedly provides the virtual reality by the symptom-induced content and the virtual reality by the symptom-enhancing content according to the user's mental symptoms, but according to the user's physical and psychological state by the biosignal analysis algorithm.
  • the second communication unit 360 transmits the data and the biological state information of the user by using the predetermined biosignal analysis reference data and the biosignal analysis algorithm to the outside and share the information.
  • FIG. 5 is a flowchart sequentially illustrating a control operation of the monitoring controller illustrated in FIG. 4.
  • the mental state and the physical state information of the user are determined according to the determination result. It supports symptom improvement content corresponding to the symptom improvement level so that virtual reality is supported for symptom improvement.
  • FIG. 6 is a diagram illustrating a symptom improving virtual environment content supporting method of the symptom improving support unit of FIG. 5.
  • a symptom corresponding to a symptom improvement level such that virtual reality is supported for symptom improvement corresponding to the mental state and the physical state information of the user according to the mental state and the physical state of the user determined in real time.
  • the improved content may be supported.
  • the virtual reality by the symptom-induced content and the virtual reality by the symptom-improved content are selectively and repeatedly provided according to the determined mental and physical state of the user.
  • the symptom induction or symptom improvement level is adjusted according to the physical and psychological state of the user by the biosignal analysis algorithm to be provided to the virtual reality.
  • the virtual reality by symptom-induced content and the virtual reality by symptom-enhancing content are selectively and repeatedly provided according to the mental symptoms of the user. By adjusting to provide virtual reality to the user's mental symptoms are improved and treated.
  • the change in the biosignal of the user in contact with the content of the virtual environment is analyzed in real time and linked with the analyzed result.
  • the system for improving mental illness using the virtual reality support content and the biosignal analysis result of the present invention is a device for implementing a virtual environment that provides a virtual environment content including a symptom causing or symptom improving content so that a user may encounter virtual reality.
  • Bio-signal detection device that detects and real-time biological signal data and shares data-signed bio-signal information, and monitors and analyzes the status of user's bio-signal changes in real time to induce or improve symptoms according to the mental and physical state of the user It includes a monitoring control unit for controlling to provide the content selectively, by changing the virtual environment to improve the mental illness in conjunction with the analysis of the bio-signal changes of the user in contact with the content of the virtual environment in real time to improve the mental disease , Addiction disease, depression, anxiety , There are effects that can improve a variety of mental illnesses such as stress, illness, it can be used in the medical industry sector overall.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Primary Health Care (AREA)
  • Business, Economics & Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Social Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Developmental Disabilities (AREA)
  • Tourism & Hospitality (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • General Business, Economics & Management (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Strategic Management (AREA)
  • Marketing (AREA)
  • Human Resources & Organizations (AREA)
  • Economics (AREA)
  • Computer Graphics (AREA)
  • Computer Hardware Design (AREA)
  • General Engineering & Computer Science (AREA)
  • Software Systems (AREA)
  • Educational Technology (AREA)
  • Databases & Information Systems (AREA)

Abstract

L'invention concerne un système pour soigner une maladie mentale employant un contenu soutenu par une réalité virtuelle et le résultat d'une analyse de bio-signaux. La présente invention apporte la possibilité de soigner diverses maladies mentales, comme la dépendance, la dépression, l'anxiété et les troubles liés au stress, en analysant en temps réel des variations du bio-signal d'un utilisateur exposé à un contenu dans un environnement virtuel et en modifiant et en présentant, en conjonction avec le résultat analysé, l'environnement virtuel de telle façon que la maladie mentale puisse être soignée.
PCT/KR2017/004998 2016-05-18 2017-05-15 Système pour soigner une maladie mentale employant un contenu soutenu par une réalité virtuelle et le résultat d'une analyse de bio-signaux Ceased WO2017200243A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2016-0060988 2016-05-18
KR1020160060988A KR20170130204A (ko) 2016-05-18 2016-05-18 가상현실 지원 콘텐츠와 생체신호 분석 결과를 활용한 정신 질환 개선 시스템

Publications (1)

Publication Number Publication Date
WO2017200243A1 true WO2017200243A1 (fr) 2017-11-23

Family

ID=60326058

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/004998 Ceased WO2017200243A1 (fr) 2016-05-18 2017-05-15 Système pour soigner une maladie mentale employant un contenu soutenu par une réalité virtuelle et le résultat d'une analyse de bio-signaux

Country Status (2)

Country Link
KR (1) KR20170130204A (fr)
WO (1) WO2017200243A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108338799A (zh) * 2018-01-30 2018-07-31 重庆云日创心教育科技有限公司 基于vr沙盘的心理评估系统及评估方法
CN111128384A (zh) * 2019-12-31 2020-05-08 慧择保险经纪有限公司 一种人体信息变化程度获得方法及装置
CN119867694A (zh) * 2025-03-31 2025-04-25 湖南舱宇医疗器械科技有限公司 结合虚拟现实技术的心率变异性数据分析反馈方法及系统

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101953612B1 (ko) * 2017-12-22 2019-03-04 동아대학교 산학협력단 가상현실을 이용하는 노출훈련을 통한 공황장애 치료장치
KR102170379B1 (ko) * 2018-10-17 2020-10-28 고려대학교 산학협력단 외상 후 스트레스 장애 환자를 위한 가상현실 기반 노출 치료용 컨텐츠 제공 방법 및 장치
KR102365118B1 (ko) * 2018-10-29 2022-02-22 사회복지법인 삼성생명공익재단 생체 신호 분석 시스템 및 이를 이용한 생체 신호 분석 방법
KR102020598B1 (ko) * 2018-12-11 2019-09-10 전자부품연구원 생체신호 센서 기반 정신질환 진단 및 치유를 위한 바이오피드백 시스템
KR102104202B1 (ko) * 2019-03-13 2020-05-29 영산대학교산학협력단 가상 현실을 사용한 인지행동치료 장치
KR102097246B1 (ko) * 2019-08-26 2020-05-29 경희대학교 산학협력단 복합적 스트레스 지수에 기반한 스트레스 관리 방법
KR102420599B1 (ko) * 2019-11-14 2022-07-20 김동섭 가상현실을 이용한 심리치료 시스템 및 그것의 제어방법
KR102271378B1 (ko) 2020-01-07 2021-06-29 재단법인 대구경북첨단의료산업진흥재단 착용형 디스플레이를 이용한 인지기능 개선 방법, 장치 및 시스템
KR20220012139A (ko) * 2020-07-22 2022-02-03 사회복지법인 삼성생명공익재단 사용자의 심리가 안정화되도록 사용자에게 인지행동 훈련을 위한 가상 현실 컨텐츠를 제공하는 시스템 및 방법
KR102269428B1 (ko) * 2020-10-29 2021-06-29 주식회사 엑스알텍 인공지능과 빅데이터를 기반으로 하고 가상 현실을 활용한 치매 및 뇌질환 진단, 예방 치료 시스템 및 솔루션
CN112870521A (zh) * 2021-01-11 2021-06-01 西安中盛凯新技术发展有限责任公司 一种沉浸式运动心理康复训练系统
KR102654594B1 (ko) * 2021-03-18 2024-04-04 홍은정 비대면 심리 치료 서비스 시스템
RU2766391C1 (ru) * 2021-04-28 2022-03-15 Елена Леонидовна Малиновская Способ анализа поведения испытуемого для выявления его психологических особенностей посредством технологий виртуальной реальности
KR20230090095A (ko) * 2021-12-14 2023-06-21 한국전자기술연구원 차량을 이용한 심신안정 시스템 및 그 서비스 제공 방법
KR102391177B1 (ko) * 2021-12-15 2022-04-27 박준 가상의 오감 감각 전달을 활용한 심리 변화 유도 방법
KR102814888B1 (ko) * 2021-12-31 2025-05-30 주식회사 후원 Vr 콘텐츠를 이용한 틱 증세 질환자의 증상 완화 및 관리 시스템
KR102737399B1 (ko) * 2022-03-21 2024-12-03 주식회사 휴서카디안 일주기 리듬을 활용한 메타버스 기반 서비스 제공 장치 및 방법
KR102565239B1 (ko) * 2023-05-24 2023-08-11 주식회사 메디마인드 기설정된 시간 이내에 공황 장애 상태를 경험한 사용자에게 컨텐츠를 제공하는 방법 및 이를 이용한 컴퓨팅 장치

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020035030A (ko) * 2002-02-25 2002-05-09 (주)블루미디어텍 정신 질환 환자를 치료하기 위한 가상 환경 시스템과 상기시스템을 이용한 치료방법
KR20040037608A (ko) * 2002-10-29 2004-05-07 한국전자통신연구원 정신질환 치료를 위한 가상현실 게임 운영시스템 및 그 방법
KR20090001472A (ko) * 2007-04-17 2009-01-09 사회복지법인 서천재단 알코올중독 환자를 위한 맞춤형 가상환경 혐오자극 제공 방법과 시스템 및 이 방법을 수행하는 프로그램이 수록되어 컴퓨터로 읽을 수 있는 기록매체
KR20140015678A (ko) * 2012-07-06 2014-02-07 계명대학교 산학협력단 생체신호 피드백을 이용한 맞춤 가상현실 운동 시스템
KR20140099569A (ko) * 2013-01-31 2014-08-13 대구가톨릭대학교산학협력단 소아정신질환 검사 및 치료 시스템 및 소아정신질환 검사 및 치료 방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020035030A (ko) * 2002-02-25 2002-05-09 (주)블루미디어텍 정신 질환 환자를 치료하기 위한 가상 환경 시스템과 상기시스템을 이용한 치료방법
KR20040037608A (ko) * 2002-10-29 2004-05-07 한국전자통신연구원 정신질환 치료를 위한 가상현실 게임 운영시스템 및 그 방법
KR20090001472A (ko) * 2007-04-17 2009-01-09 사회복지법인 서천재단 알코올중독 환자를 위한 맞춤형 가상환경 혐오자극 제공 방법과 시스템 및 이 방법을 수행하는 프로그램이 수록되어 컴퓨터로 읽을 수 있는 기록매체
KR20140015678A (ko) * 2012-07-06 2014-02-07 계명대학교 산학협력단 생체신호 피드백을 이용한 맞춤 가상현실 운동 시스템
KR20140099569A (ko) * 2013-01-31 2014-08-13 대구가톨릭대학교산학협력단 소아정신질환 검사 및 치료 시스템 및 소아정신질환 검사 및 치료 방법

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108338799A (zh) * 2018-01-30 2018-07-31 重庆云日创心教育科技有限公司 基于vr沙盘的心理评估系统及评估方法
CN111128384A (zh) * 2019-12-31 2020-05-08 慧择保险经纪有限公司 一种人体信息变化程度获得方法及装置
CN111128384B (zh) * 2019-12-31 2024-01-26 慧择保险经纪有限公司 一种人体信息变化程度获得方法及装置
CN119867694A (zh) * 2025-03-31 2025-04-25 湖南舱宇医疗器械科技有限公司 结合虚拟现实技术的心率变异性数据分析反馈方法及系统

Also Published As

Publication number Publication date
KR20170130204A (ko) 2017-11-28

Similar Documents

Publication Publication Date Title
WO2017200243A1 (fr) Système pour soigner une maladie mentale employant un contenu soutenu par une réalité virtuelle et le résultat d'une analyse de bio-signaux
Bernal et al. Galea: A physiological sensing system for behavioral research in Virtual Environments
Karim et al. Neural internet: Web surfing with brain potentials for the completely paralyzed
Onose et al. On the feasibility of using motor imagery EEG-based brain–computer interface in chronic tetraplegics for assistive robotic arm control: a clinical test and long-term post-trial follow-up
Chittaro et al. Affective computing vs. affective placebo: Study of a biofeedback-controlled game for relaxation training
Bekele et al. Design of a virtual reality system for affect analysis in facial expressions (VR-SAAFE); application to schizophrenia
US12383187B2 (en) Method and system for monitoring a level of non-pharmacologically-induced modified state of consciousness
Ikegami et al. A region-based two-step P300-based brain–computer interface for patients with amyotrophic lateral sclerosis
McFarland et al. BCI in practice
CN1555243A (zh) 视觉检查的系统和方法
WO2017200244A1 (fr) Système d'évaluation de symptômes psychiatriques utilisant un contenu audiovisuel et une analyse de biosignal
WO2022034048A1 (fr) Procédé et système de mesure d'un niveau d'anxiété
Rezvani et al. A review on the performance of brain-computer interface systems used for patients with locked-in and completely locked-in syndrome
Hanshans et al. Inducing and measuring acute stress in virtual reality: Evaluation of canonical physiological stress markers and measuring methods
WO2022034205A1 (fr) Procédé et système de mesure d'un niveau d'anxiété associé et/ou corrélé à un niveau d'un état de conscience modifié et/ou d'un niveau de douleur
WO2021245268A1 (fr) Procédé et système de surveillance d'un niveau de douleur
US20230140419A1 (en) System for the automatic evaluation of cognition and consciousness of an individual through external stimulations
WO2021040206A1 (fr) Procédé et système de gestion du sommeil de type personnalisé
Young-McCaughan et al. Measurement of opioid-induced sedation
Badesa et al. Evaluation of performance and heart rate variability during intensive usage of a BCI-controlled hand exoskeleton
WO2023140467A1 (fr) Procédé et dispositif de régulation de niveaux d'anxiété à l'aide de la réalité virtuelle
Kübler et al. The thought translation device
McCullagh et al. An SSVEP and eye tracking hybrid BNCI: potential beyond communication and control
Abuhashish et al. A Review on Interactive Hands-free Game using BCI
Barreto Non-intrusive physiological monitoring for affective sensing of computer users

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17799601

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 13.03.2019)

122 Ep: pct application non-entry in european phase

Ref document number: 17799601

Country of ref document: EP

Kind code of ref document: A1